Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor Malignancies 1

Interventions

Cyclophosphamide 5fludarabine 4Specimen Handling 3alpha-Synuclein 2Magnetic Resonance Spectroscopy 2Interleukin-2 2theanine 1temsirolimus 1spartalizumab 1sodium thiosulfate 1selicrelumab 1perflutren 1malic acid 1amatuximab 1X-Rays 1Valproic Acid 1Topotecan 1Surgical Procedures, Operative 1Sunitinib 1Sulfur Hexafluoride 1Sirolimus 1Resistant Starch 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Liquid Biopsy 1KD025 1Interviews as Topic 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × malic acid × Other solid neoplasm × Clear all
NCT07325123 2026-01-08

Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors

The First Affiliated Hospital of Xinxiang Medical College

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled
Other solid neoplasm

Solid Tumor Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡